HomeClinical TopicsFDA approves first drug for myelofibrosis

FDA approves first drug for myelofibrosis

The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content